FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000218345> ?p ?o ?g. }

• W2000218345 endingPage "2764" @default.
• W2000218345 startingPage "2755" @default.
• W2000218345 abstract "Objectives:The primary objective of this study was to demonstrate equivalence of pitavastatin compared with simvastatin in the reduction of low-density lipoprotein cholesterol (LDL-C) levels in patients with primary hypercholesterolaemia or combined dyslipidaemia. Secondary objectives included achievement of National Cholesterol Education Program Adult Treatment Panel (NECP) and European Atherosclerosis Society (EAS) LDL-C goals, comparison of other lipid parameters, and assessment of safety and tolerability of the two statins.Research design and methods:A prospective, randomised, active-controlled double-blind, double-dummy, 12-week therapy trial was conducted in 857 patients with either primary hypercholesterolaemia or combined dyslipidaemia. The trial was designed to demonstrate the equivalence (non-inferiority of presumed equipotent doses) of pitavastatin compared with simvastatin. Patients were randomised to one of four groups: pitavastatin 2 mg/day, pitavastatin 4 mg/day, simvastatin 20 mg/day or simvastatin 40 mg/day. The main study limitation was restriction of the study population to those eligible for administration of simvastatin.Trial registration:This clinical trial has been registered at www.clinicaltrials.gov NCT# NCT00309777.Results:Pitavastatin 2 mg showed significantly better reductions of LDL-C (p = 0.014), non-high-density lipoprotein cholesterol (non-HDL-C) (p = 0.021) and total cholesterol (TC) (p = 0.041) compared with simvastatin 20 mg and led to more patients achieving the EAS LDL-C treatment target. Reduction of LDL-C in the pitavastatin 2 mg group was 39% compared with 35% in the simvastatin 20 mg group. Pitavastatin 4 mg showed similar effects on all lipid parameters to simvastatin 40 mg. The reductions in LDL-C were 44% and 43%, respectively. The safety profiles of pitavastatin and simvastatin were similar at the two dose levels. Pitavastatin was considered superior to simvastatin in terms of percent reduction of LDL-C in the lower dose group comparison and proved to be equivalent to simvastatin in percent reduction of LDL-C in the higher-dose group.Conclusion:As compared with simvastatin, an established first-line lipid-lowering agent, pitavastatin is an efficacious treatment choice in patients with primary hypercholesterolaemia or combined dyslipidaemia." @default.
• W2000218345 created "2016-06-24" @default.
• W2000218345 creator A5009401009 @default.
• W2000218345 creator A5032552822 @default.
• W2000218345 creator A5046853816 @default.
• W2000218345 creator A5080101019 @default.
• W2000218345 date "2009-09-29" @default.
• W2000218345 modified "2023-09-27" @default.
• W2000218345 title "Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia" @default.
• W2000218345 cites W110324665 @default.
• W2000218345 cites W12423254 @default.
• W2000218345 cites W1964754630 @default.
• W2000218345 cites W1972966413 @default.
• W2000218345 cites W1973523240 @default.
• W2000218345 cites W1979040664 @default.
• W2000218345 cites W1984360552 @default.
• W2000218345 cites W2002405990 @default.
• W2000218345 cites W2004753352 @default.
• W2000218345 cites W2013014511 @default.
• W2000218345 cites W2038140751 @default.
• W2000218345 cites W2043180355 @default.
• W2000218345 cites W2044564545 @default.
• W2000218345 cites W2048859524 @default.
• W2000218345 cites W2049308410 @default.
• W2000218345 cites W2051707451 @default.
• W2000218345 cites W2052855730 @default.
• W2000218345 cites W2057674977 @default.
• W2000218345 cites W2067322348 @default.
• W2000218345 cites W2082220828 @default.
• W2000218345 cites W2089356907 @default.
• W2000218345 cites W2095421226 @default.
• W2000218345 cites W2100270330 @default.
• W2000218345 cites W2101697950 @default.
• W2000218345 cites W2106343349 @default.
• W2000218345 cites W2116404316 @default.
• W2000218345 cites W2121933788 @default.
• W2000218345 cites W2124172014 @default.
• W2000218345 cites W2128818358 @default.
• W2000218345 cites W2140072878 @default.
• W2000218345 cites W2140332812 @default.
• W2000218345 cites W2153979750 @default.
• W2000218345 cites W2154704322 @default.
• W2000218345 cites W2164542079 @default.
• W2000218345 cites W2517252201 @default.
• W2000218345 cites W3021659692 @default.
• W2000218345 cites W4210993071 @default.
• W2000218345 cites W4238251256 @default.
• W2000218345 cites W4242564969 @default.
• W2000218345 cites W424467158 @default.
• W2000218345 cites W4256285396 @default.
• W2000218345 doi "https://doi.org/10.1185/03007990903290886" @default.
• W2000218345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19785568" @default.
• W2000218345 hasPublicationYear "2009" @default.
• W2000218345 type Work @default.
• W2000218345 sameAs 2000218345 @default.
• W2000218345 citedByCount "69" @default.
• W2000218345 countsByYear W20002183452012 @default.
• W2000218345 countsByYear W20002183452013 @default.
• W2000218345 countsByYear W20002183452014 @default.
• W2000218345 countsByYear W20002183452015 @default.
• W2000218345 countsByYear W20002183452016 @default.
• W2000218345 countsByYear W20002183452017 @default.
• W2000218345 countsByYear W20002183452018 @default.
• W2000218345 countsByYear W20002183452020 @default.
• W2000218345 countsByYear W20002183452021 @default.
• W2000218345 countsByYear W20002183452022 @default.
• W2000218345 countsByYear W20002183452023 @default.
• W2000218345 crossrefType "journal-article" @default.
• W2000218345 hasAuthorship W2000218345A5009401009 @default.
• W2000218345 hasAuthorship W2000218345A5032552822 @default.
• W2000218345 hasAuthorship W2000218345A5046853816 @default.
• W2000218345 hasAuthorship W2000218345A5080101019 @default.
• W2000218345 hasConcept C126322002 @default.
• W2000218345 hasConcept C134018914 @default.
• W2000218345 hasConcept C197934379 @default.
• W2000218345 hasConcept C2776329913 @default.
• W2000218345 hasConcept C2776692505 @default.
• W2000218345 hasConcept C2776839432 @default.
• W2000218345 hasConcept C2777482532 @default.
• W2000218345 hasConcept C2778163477 @default.
• W2000218345 hasConcept C2778375690 @default.
• W2000218345 hasConcept C2778402494 @default.
• W2000218345 hasConcept C2778657065 @default.
• W2000218345 hasConcept C2779519902 @default.
• W2000218345 hasConcept C2780072125 @default.
• W2000218345 hasConcept C2780578515 @default.
• W2000218345 hasConcept C2908647359 @default.
• W2000218345 hasConcept C511355011 @default.
• W2000218345 hasConcept C71924100 @default.
• W2000218345 hasConcept C90924648 @default.
• W2000218345 hasConcept C98274493 @default.
• W2000218345 hasConcept C99454951 @default.
• W2000218345 hasConceptScore W2000218345C126322002 @default.
• W2000218345 hasConceptScore W2000218345C134018914 @default.
• W2000218345 hasConceptScore W2000218345C197934379 @default.
• W2000218345 hasConceptScore W2000218345C2776329913 @default.
• W2000218345 hasConceptScore W2000218345C2776692505 @default.
• W2000218345 hasConceptScore W2000218345C2776839432 @default.

• next